LHON awareness

Views & Analysis

It’s hard to imagine suddenly losing your sight in your 20s, but that’s what happened to Richard Wheeler when he developed

News

Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.